The combined use of X-ray Crystallography and Mass Spectrometry represents a valuable strategy to investigate and characterize protein metalation induced by anticancer metal-based drugs. Here, we summarize a series of significant results recently obtained by our laboratories in the examination of the structures of several adducts of proteins with representative metallodrugs (mostly containing ruthenium, gold and platinum). The general mechanisms of protein metalation that emerge from a careful comparative analysis of these structures are illustrated and their mechanicistic implications discussed. Possible directions for future work in the field are delineated
Protein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies / Messori, L.; Merlino, A.. - In: CHEMICAL COMMUNICATIONS. - ISSN 1359-7345. - 53:85(2017), pp. 11622-11633. [10.1039/c7cc06442j]
Protein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies
Merlino, A.
2017
Abstract
The combined use of X-ray Crystallography and Mass Spectrometry represents a valuable strategy to investigate and characterize protein metalation induced by anticancer metal-based drugs. Here, we summarize a series of significant results recently obtained by our laboratories in the examination of the structures of several adducts of proteins with representative metallodrugs (mostly containing ruthenium, gold and platinum). The general mechanisms of protein metalation that emerge from a careful comparative analysis of these structures are illustrated and their mechanicistic implications discussed. Possible directions for future work in the field are delineatedI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.